Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
Cell Rep Med ; 4(6): 101070, 2023 06 20.
Article in English | MEDLINE | ID: mdl-37269826

ABSTRACT

The strong dependency of almost all malignant tumors on methionine potentially offers a pathway for cancer treatment. We engineer an attenuated strain of Salmonella typhimurium to overexpress an L-methioninase with the aim of specifically depriving tumor tissues of methionine. The engineered microbes target solid tumors and induce a sharp regression in several very divergent animal models of human carcinomas, cause a significant decrease in tumor cell invasion, and essentially eliminate the growth and metastasis of these tumors. RNA sequencing analyses reveal that the engineered Salmonella reduce the expression of a series of genes promoting cell growth, cell migration, and invasion. These findings point to a potential treatment modality for many metastatic solid tumors, which warrants further tests in clinical trials.


Subject(s)
Methionine , Neoplasms , Animals , Humans , Methionine/metabolism , Methionine/therapeutic use , Neoplasms/drug therapy , Racemethionine/metabolism , Salmonella typhimurium/genetics , Salmonella typhimurium/metabolism , Models, Animal
SELECTION OF CITATIONS
SEARCH DETAIL